Nexaph
Ordered peptides from Nexaph? Mail in a sample (US only) and let us test it.
Test my supplyNexaph's purity-focus record is broad and recent, with GHK-Cu the clearest strength and Retatrutide and Tirzepatide showing cleaner recent runs after earlier volatility. Weakness is dispersed across Tesamorelin, Semaglutide and CJC-1295, where purity misses, fill outliers and uneven batch IDs keep confidence mixed.
Corporate records, RDAP data and site emails trace Nexaph through a fragmented operator identity rather than a clean public counterparty. The report maps sister-brand infrastructure, COA-cloning pathways and a certification/payment layer that changes buyer recourse.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Nexaph rows.
Cancel anytime
Ordered peptides from Nexaph? Mail in a sample (US only) and let us test it.
Test my supply| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
20 Oct 2026 | Pass | Retatrutide Nexaph | lab name | View COA | |||
9 Oct 2026 | Pass | GHK-Cu Nexaph | lab name | View COA | |||
5 Oct 2026 | Pass | CJC-1295 (No DAC) Nexaph | lab name | View COA | |||
1 Oct 2026 | Pass | BPC-157 Nexaph | lab name | View COA | |||
25 Sep 2026 | Pass | MOTS-c Nexaph | lab name | View COA | |||
24 Sep 2026 | Pass | BPC-157 Nexaph | lab name | View COA | |||
24 Sep 2026 | Pass | Tirzepatide Nexaph | lab name | View COA | |||
20 Sep 2026 | Fail | Tirzepatide Nexaph | lab name | View COA | |||
18 Sep 2026 | Pass | BPC-157 Nexaph | lab name | View COA | |||
16 Sep 2026 | Pass | Retatrutide Nexaph | lab name | View COA | |||
About Nexaph test results from Finnrick
Nexaph is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 16 peptides and 299 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Nexaph peptides in this dataset are BPC-157 (20 tests) and Semaglutide (15 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 200 recent tests.
Ordered peptides from Nexaph? Mail in a sample (US only) and let us test it.
Test my supply